tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
15Bullish
4Neutral
3Bearish
Oscillators
Buy
4Bullish
4Neutral
2Bearish
Moving Averages
Strong Buy
11Bullish
0Neutral
1Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 22.62, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 22.38, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Dec 26, 2025, 12:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.75
22.75
22.75
22.75
22.75
22.75
22.75
Fibonacci
22.75
22.75
22.75
22.75
22.75
22.75
22.75

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Dec 26, 2025, 12:12 PM
Period
Simple
Exponential
MA5
22.65Buy
22.68Buy
MA10
22.53Buy
22.64Buy
MA20
22.76Sell
22.62Buy
MA50
22.44Buy
22.38Buy
MA100
21.82Buy
21.84Buy
MA200
20.39Buy
20.81Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 22.64, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 21.84, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 22.44, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 21.82, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 20.39, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Dec 26, 2025, 12:12 PM
Name
Value
Action
RSI (14)
53.27
Neutral
STOCH (9,6)
85.11
Sell
STOCHRSI (14)
55.27
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
13.45
Buy
Williams %R
-50.22
Buy
CCI (14)
-6.83
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
49.07
Neutral
ROC
-2.07
Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 53.27, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 13.45, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is -6.83, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is -2.07, creating a Sell signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Strong Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 53.27, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.04, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 22.65, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 22.76, which suggests CURE is a Sell.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 22.44, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 20.39, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -50.22, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is -6.83, which suggests CURE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement